KCNJ14 encodes inwardly rectifying potassium channel Kir2.4, part of the Kir2.x family that stabilizes resting membrane potential and shapes subthreshold signaling in excitable tissues.[1][2] Inward rectifiers pass K+ more effectively into cells than out of cells across physiological voltage ranges, providing electrical damping that helps prevent uncontrolled depolarization.[1:1][3]
In neurodegeneration research, KCNJ14 is better framed as a network-modifier candidate than as a high-penetrance monogenic cause. Kir-channel balance influences neuronal firing efficiency, calcium load, and energy demand, connecting KCNJ14 biology to shared mechanisms such as excitotoxicity, oxidative stress, and mitochondrial dysfunction.[4][5][6]
| Property | Value |
|---|---|
| HGNC symbol | KCNJ14 |
| Full name | Potassium inwardly rectifying channel subfamily J member 14 |
| NCBI Gene | 3770 |
| Ensembl | ENSG00000157322 |
| UniProt | O95838 |
| Alias | Kir2.4 |
Kir2-family channels are tetramers with each subunit contributing two transmembrane segments and a pore loop that sets K+ selectivity.[1:2][3:1] Intracellular polyamines and magnesium drive inward rectification by preferentially blocking outward current at depolarized voltages.[1:3][3:2]
Kir conductance contributes to:
For Kir2.4 specifically, data indicate CNS expression with likely contributions to excitability calibration in selected neuronal ensembles.[2:1][7]
Public atlas datasets and channel-family mapping support KCNJ14 expression in brain and additional non-neural tissues.[2:2][7:1] The translational implication is that perturbation may have CNS and peripheral electrophysiologic consequences, requiring tissue-aware interpretation in therapeutic programs.
From a circuit perspective, inward-rectifier loss can increase susceptibility to repetitive depolarization, while excessive conductance can suppress adaptive responsiveness. Either direction can impair information processing when combined with pathology in synapses, myelin, or metabolism.[4:2][5:1]
Neurons with impaired stabilizing K+ currents may run at higher energetic cost due to increased spike probability and ion-pump workload. In aging or disease settings with mitochondrial compromise, this can accelerate vulnerability.[5:2][6:1]
Higher membrane excitability increases probability of calcium overload through voltage-gated and receptor-mediated pathways, reinforcing excitotoxic programs linked to synaptic failure and structural degeneration.[4:3][8]
Pro-inflammatory signaling changes membrane-channel expression and glial-neuronal coupling. Channel dysregulation can in turn amplify network instability and inflammatory tone, creating a progression loop relevant across AD/PD/ALS spectra.[9][10]
Strong Mendelian disease assignments for KCNJ14 in major neurodegenerative syndromes remain limited. Current evidence is more consistent with:
This still has clinical value: modifiers can influence rate of decline, symptom clusters, or treatment response even without causing disease independently.
No KCNJ14-specific approved therapy exists. Practical strategies include:
For precision medicine, KCNJ14 is currently strongest as a stratification and mechanistic interpretation gene.
Hibino H, Inanobe A, Furutani K, Murakami S, Findlay I, Kurachi Y. Inwardly rectifying potassium channels: their structure, function, and physiological roles. Physiological Reviews. 2010. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Karschin C, Dissmann E, Stuhmer W, Karschin A. IRK(1-3) and GIRK(1-4) inwardly rectifying K+ channel mRNAs are differentially expressed in the adult rat brain. Journal of Neuroscience. 1996. ↩︎ ↩︎ ↩︎
Nichols CG, Lopatin AN. Inward rectifier potassium channels. Annual Review of Physiology. 1997. ↩︎ ↩︎ ↩︎ ↩︎
Styr B, Slutsky I. Imbalance between firing homeostasis and synaptic plasticity drives early-phase Alzheimer's disease. Nature Neuroscience. 2018. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Mattson MP, Gleichmann M, Cheng A. Mitochondria in neuroplasticity and neurological disorders. Neuron. 2008. ↩︎ ↩︎ ↩︎ ↩︎
Johri A, Beal MF. Mitochondrial dysfunction in neurodegenerative diseases. Journal of Pharmacology and Experimental Therapeutics. 2012. ↩︎ ↩︎
Fagerberg L, Hallstrom BM, Oksvold P, et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Molecular & Cellular Proteomics. 2014. ↩︎ ↩︎
Parsons MP, Raymond LA. Extrasynaptic NMDA receptor involvement in central nervous system disorders. Neuron. 2014. ↩︎
Heneka MT, Kummer MP, Latz E. Innate immune activation in neurodegenerative disease. Nature Reviews Immunology. 2014. ↩︎ ↩︎
Frere S, Slutsky I. Alzheimer's disease: from firing instability to homeostasis network collapse. Neuron. 2018. ↩︎ ↩︎